We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

38 hedge funds and large institutions have $36.2M invested in Annovis Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

1.93% less ownership

Funds ownership: 16.01% → 14.08% (-1.9%)

33% less funds holding

Funds holding: 57 → 38 (-19)

67% less capital invested

Capital invested by funds: $109M → $36.2M (-$72.7M)

68% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 28

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
-19
Holders Change %
-33.33%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
14
Reduced
10
Closed
28
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$5.61M
2
Millennium Management
Millennium Management
New York
+$3.57M
3
WFAG
Wescott Financial Advisory Group
Pennsylvania
+$2.39M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.14M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$8.86M
2
EI
EAM Investors
California
-$4.16M
3
ACM
AIGH Capital Management
Maryland
-$3.45M
4
EGI
EAM Global Investors
California
-$2.53M
5
Goldman Sachs
Goldman Sachs
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
WSFS
26
Wilmington Savings Fund Society
Delaware
$298K – – –
Northern Trust
27
Northern Trust
Illinois
$289K – – –
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$251K +$455K +7,908 New
RAM
29
Redmond Asset Management
Virginia
$250K +$7.36K +128 +2%
WANY
30
Wealthspire Advisors (New York)
New York
$238K +$144K +2,500 +50%
VEA
31
Virtus ETF Advisers
New York
$76K -$7.53K -131 -5%
Rockefeller Capital Management
32
Rockefeller Capital Management
New York
$31K – – –
UBS Group
33
UBS Group
Switzerland
$12K -$44.6K -775 -66%
SWM
34
Spire Wealth Management
Virginia
$10K -$25.6K -445 -59%
TRCT
35
Tower Research Capital (TRC)
New York
$7K +$13.1K +227 New
OSAM
36
O'Shaughnessy Asset Management
Connecticut
$1K – – –
IC
37
Ikarian Capital
Texas
– -$8.86M -103,527 Closed
EI
38
EAM Investors
California
– -$4.16M -48,643 Closed
EGI
39
EAM Global Investors
California
– -$2.53M -29,590 Closed
Goldman Sachs
40
Goldman Sachs
New York
– -$2.21M -25,819 Closed
PPA
41
Parametric Portfolio Associates
Washington
– -$1.91M -22,331 Closed
LSA
42
L & S Advisors
California
– -$1.67M -19,530 Closed
SEI Investments
43
SEI Investments
Pennsylvania
– -$1.3M -15,244 Closed
DC
44
Diametric Capital
Massachusetts
– -$1.07M -12,458 Closed
ACM
45
ACT Capital Management
Pennsylvania
– -$1.03M -12,000 Closed
BFM
46
Boothbay Fund Management
New York
– -$1.01M -11,756 Closed
JP Morgan Chase
47
JP Morgan Chase
New York
– -$687K -8,024 Closed
PCM
48
Prelude Capital Management
New York
– -$665K -7,770 Closed
SAM
49
Silvercrest Asset Management
New York
– -$616K -7,200 Closed
AWM
50
Absher Wealth Management
North Carolina
– -$542K -6,329 Closed
1
2
3

ANVS Hedge Fund Activity: Q3 2021 in Review

38 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q3 2021, worth a combined $36.2M — down 67% from $109M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ANVS and 9 opened new positions — a net loss of 19 holders — while 10 trimmed existing stakes and 14 added.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $5.61M. The largest seller was Ikarian Capital, exiting entirely with an estimated $8.86M sold.

  • 38 institutional investors held Annovis Bio (ANVS) as of Q3 2021, down from 57 in Q2 2021.
  • Funds reported $36.2M of Annovis Bio stock for Q3 2021, down 67% quarter-over-quarter.
  • 9 funds opened new Annovis Bio positions in Q3 2021 and 28 closed out, a net change of -19 holders.
  • The largest Annovis Bio buyer in Q3 2021 was Two Sigma Investments, an estimated $5.61M added.
  • The largest Annovis Bio seller in Q3 2021 was Ikarian Capital, an estimated $8.86M sold.

Based on aggregated 13F filings for Q3 2021.